EA
60
-5
PLD
45
-5
COF
62
3
AXP
67
-2
PEP
39
-9
RCL
83
-2
CRM
60
-7
SPG
60
2
NI
72
4
PG
50
2
UPS
48
2
UNH
57
-2
RIG
43
-7
HAL
48
-3
AIV
64
4
TEL
60
-8
WAT
48
-11
SBUX
37
-2
MCD
52
-5
THC
60
-5
EA
60
-5
PLD
45
-5
COF
62
3
AXP
67
-2
PEP
39
-9
RCL
83
-2
CRM
60
-7
SPG
60
2
NI
72
4
PG
50
2
UPS
48
2
UNH
57
-2
RIG
43
-7
HAL
48
-3
AIV
64
4
TEL
60
-8
WAT
48
-11
SBUX
37
-2
MCD
52
-5
THC
60
-5
Financhill
Back

Purple Innovation Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

PRPL
Purple Innovation

Last Price:
0.82
Seasonality Move:
28.17%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
30
Purple Innovation (PRPL) is a Sell

Is Purple Innovation a Buy, Sell or Hold?

  • The current Purple Innovation [PRPL] share price is $0.82. The Score for PRPL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PRPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPL Stock Price Chart

What is Purple Innovation's stock price today?

  • The Purple Innovation share price today is $0.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPL is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PRPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 39.98 Sell
Chaikin Money Flow: -322662 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.84 - 0.92) Sell
Bollinger Bands (100): (0.9 - 1.22) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PRPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.85 Sell
20-day SMA: 0.88 Sell
50-day SMA: 0.94 Sell
200-day SMA: 1.27 Sell
8-day EMA: 0.85 Sell
20-day EMA: 0.88 Sell
50-day EMA: 0.95 Sell
200-day EMA: 1.25 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Purple Innovation Earnings Growth & PRPL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.17 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Purple Innovation Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):